SCHEMBL3933703

SCHEMBL3933703

CS(=O)(=O)Oc1ccc2ccncc2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 1/20 0.46
PIK3CD O00329 2/20 0.44
PIK3CA P42336 2/20 0.44
PIK3CB P42338 2/20 0.44
PIK3CG P48736 2/20 0.44
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA9 Q16790 1/20 0.42
MRGPRX4 Q96LA9 1/20 0.42
ALDH1A1 P00352 2/20 0.41
MAPT P10636 2/20 0.41
KDM4E B2RXH2 1/20 0.41
HPGD P15428 1/20 0.41
PRKCZ Q05513 2/20 0.40
SCN9A Q15858 1/20 0.40
CYP3A4 P08684 1/20 0.40
PORCN Q9H237 1/20 0.40
DYRK3 O43781 1/20 0.40
ROCK2 O75116 1/20 0.40
PRKD3 O94806 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1401395 0.81 CA1 (0.44) IKBKBPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL1395608 0.78 CA2 (0.66) CA1CA2CA9ALDH1A1MAPT
SCHEMBL127857 0.77 CYP11B2 (0.58) IKBKBMAPTCYP3A4NPC1RAB9A
SCHEMBL7287307 0.75 CA1 (0.45) IKBKBCA1CA2CA9MRGPRX4
SCHEMBL20364928 0.75 L3MBTL1 (0.56) CA1CA2CA9ALDH1A1KDM4E
SCHEMBL31499216 0.74 PTGS2 (0.54) CA1CA2CA9ALDH1A1KDM4E
SCHEMBL12567839 0.74 PIK3CD (0.45) PIK3CDPIK3CAPIK3CBPIK3CGPRKCZ
SCHEMBL9826855 0.73 CA12 (0.49) IKBKBCA9MRGPRX4ALDH1A1MAPT
SCHEMBL1395599 0.73 CYP2A6 (0.52) CA1CA2CA9ALDH1A1MAPT
SCHEMBL30497290 0.72 IKBKB (0.48) IKBKBMRGPRX4ALDH1A1MAPTPRKCZ

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2043638-A2 USE OF TRIFLUOROMETHYL SUBSTITUTED BENZAMIDES IN THE TREATMENT OF NEUROLOGICAL DISORDERS Novartis AG (CH) 2009-04-08 EP disclosed
WO-2008008821-A2 USE OF TRIFLUOROMETHYL SUBSTITUTED BENZAMIDES IN THE TREATMENT OF NEUROLOGICAL DISORDERS NOVARTIS AG (CH) 2008-01-17 WO disclosed